1
|
Jodar M, Barral Y, Leiva M, Castillo J, Barrio R, Agustí I, Borràs A, Carrillo P, Matheu R, Ferreti R, Herrero J, Reimundo P, Navero-Castillejos J, Casals G, Guimerà M, Corral JM, Martinez M, Carbonell M, Bassas L, Manau D, Oliva R. Reversible effects of the SARS-CoV-2 on semen parameters. Syst Biol Reprod Med 2024; 70:261-271. [PMID: 39217625 DOI: 10.1080/19396368.2024.2390514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 08/02/2024] [Accepted: 08/05/2024] [Indexed: 09/04/2024]
Abstract
Despite that the SARS-CoV-2 pandemic has been controlled, it has affected a large proportion of the population, raising some concerns about potential sequelae in men at reproductive age. To contribute to the clarification of this issue, we performed a retrospective study comparing semen parameters values before and after confirmed SARS-CoV-2 infection in a large cohort of infertile men, compared to a control group that did not undergo SARS-CoV-2 infection. Wilcoxon test on paired samples and general linear regression model showed that SARS-CoV-2 infection has a detrimental effect on semen volume values (p < 0.005). However, semen volume seems to be significantly lower only during the first spermatogenic cycle after SARS-COV-2 infection (p < 0.005) and mainly in unvaccinated patients (p < 0.05). In addition, we detected alterations in progressive motility in patients infected with the alpha SARS-COV-2 strain (p < 0.05). In conclusion, our results show that although SARS-CoV-2 has a small effect on semen volume and sperm motility in infertile men, depending on the infectious strain or vaccination status, pre-infection values of semen parameters appear to be restored over one spermatogenic cycle after infection.
Collapse
Affiliation(s)
- Meritxell Jodar
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Biochemistry and Molecular Genetics Service (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Yasmina Barral
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Marina Leiva
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
| | - Judit Castillo
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
| | - Ruth Barrio
- Catalan Transplant Organization (OCATT), Catalan Health Service (CatSalut), Barcelona, Spain
| | - Inés Agustí
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Aina Borràs
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Pilar Carrillo
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Roger Matheu
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Urology and Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Raquel Ferreti
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Julio Herrero
- Maternal-Foetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Pilar Reimundo
- Laboratory of Assisted Reproduction and Andrology, Area of Clinical Biochemistry, Vall d'Hebron Clinical Laboratories, Vall d'Hebron University Hospital, Barcelona, Spain
| | - Jessica Navero-Castillejos
- Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
| | - Gemma Casals
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Gynecological Endocrinology and Human Reproduction Group, Barcelona, Spain
| | - Marta Guimerà
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Juan Manuel Corral
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Urology and Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Mikel Martinez
- Microbiology (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Melchor Carbonell
- Maternal-Foetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Lluís Bassas
- Laboratory of Seminology and Embryology, Andrology Service, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau- Fundació Puigvert, Barcelona, Spain
| | - Dolors Manau
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Gynecological Endocrinology and Human Reproduction Group, Barcelona, Spain
| | - Rafael Oliva
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Biochemistry and Molecular Genetics Service (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| |
Collapse
|
2
|
V J A, P J A, T M A, Akhigbe RE. SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLoS One 2024; 19:e0307396. [PMID: 39250513 PMCID: PMC11383251 DOI: 10.1371/journal.pone.0307396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Accepted: 07/04/2024] [Indexed: 09/11/2024] Open
Abstract
BACKGROUND Since the discovery of COVID-19 in December 2019, the novel virus has spread globally causing significant medical and socio-economic burden. Although the pandemic has been curtailed, the virus and its attendant complication live on. A major global concern is its adverse impact on male fertility. AIM This study was aimed to give an up to date and robust data regarding the effect of COVID-19 on semen variables and male reproductive hormones. MATERIALS AND METHODS Literature search was performed according to the recommendations of PRISMA. Out of the 852 studies collected, only 40 were eligible for inclusion in assessing the effect SARS-CoV-2 exerts on semen quality and androgens. More so, a SWOT analysis was conducted. RESULTS The present study demonstrated that SARS-CoV-2 significantly reduced ejaculate volume, sperm count, concentration, viability, normal morphology, and total and progressive motility. Furthermore, SARS-CoV-2 led to a reduction in circulating testosterone level, but a rise in oestrogen, prolactin, and luteinizing hormone levels. These findings were associated with a decline in testosterone/luteinizing hormone ratio. CONCLUSIONS The current study provides compelling evidence that SARS-CoV-2 may lower male fertility by reducing semen quality through a hormone-dependent mechanism; reduction in testosterone level and increase in oestrogen and prolactin levels.
Collapse
Affiliation(s)
- Ashonibare V J
- Medical Faculty, Department of Cardiovascular Surgery and Research Group for Experimental Surgery, Cardiovascular Regenerative Medicine and Tissue Engineering 3D Lab, Heinrich Heine University, Düsseldorf, Germany
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria
| | - Ashonibare P J
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria
| | - Akhigbe T M
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria
- Department of Agronomy, Breeding and Genetic Unit, Osun State University, Osun State, Nigeria
| | - R E Akhigbe
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria
| |
Collapse
|
3
|
Anastácio BM, Monteiro PB, Capelo MF. The impact of COVID-19 on male reproductive health: a Systematic Review. JBRA Assist Reprod 2024; 28:483-488. [PMID: 38712833 PMCID: PMC11349263 DOI: 10.5935/1518-0557.20240028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Accepted: 01/19/2024] [Indexed: 05/08/2024] Open
Abstract
OBJECTIVE This systematic literature review aims to assess the impact of COVID-19 on male fertility. DATA SOURCES The study draws upon data extracted from PubMed, SciELO, and LILACS databases. STUDY SELECTION The review incorporates cross-sectional studies, cohort studies, and clinical trials, encompassing investigations related to the subject matter. The studies included were published between June 2020 and March 2023, and encompassed content in English, Portuguese, and Spanish. Exclusion criteria encompassed review articles, case reports, abstracts, studies involving animal models, duplicate articles, and letters to the editor. DATA COLLECTION Data extracted included the author's name and publication year, the number of patients studied, patient age, the presence of COVID-19 in semen, observed hormonal changes, and alterations in seminal quality. CONCLUSIONS While hormonal changes and a decline in seminal quality were observed in COVID-19 patients, the virus itself was not detected in semen in the analyzed articles, which contradicts certain findings in the existing literature. It is essential to note that methodologies in the studies were diverse, and, due to the novelty of this infection, it is premature to definitively ascertain its long-term effects on male fertility or whether fertility can recover after a period of convalescence. This underscores the necessity for further research, utilizing more robust methodologies such as cohort studies.
Collapse
Affiliation(s)
| | - Paula Bruno Monteiro
- Christus University Center (UNICHRISTUS), Biomedicine Department.
Fortaleza, Ceará, Brazil
| | | |
Collapse
|
4
|
Matzkin ME, Beguerie C, De Zuñiga I, Martinez G, Frungieri MB. Impact of COVID-19 on sperm quality and the prostaglandin and polyamine systems in the seminal fluid. Andrology 2024; 12:1078-1095. [PMID: 37873918 DOI: 10.1111/andr.13548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 09/15/2023] [Accepted: 10/12/2023] [Indexed: 10/25/2023]
Abstract
BACKGROUND The implications of SARS-CoV-2 infection on male fertility remain largely unknown. Besides their well-known pro- and anti-inflammatory actions, prostaglandins and polyamines are present in semen, where they play key roles in sperm quality. OBJECTIVES To analyze semen parameters, oxidative profile and the seminal fluid prostaglandin and polyamine systems in samples collected from individuals without coronavirus disease 2019 diagnosis and men who recovered from coronavirus disease 2019. MATERIALS AND METHODS This study compared semen collected from men without positive coronavirus disease 2019 diagnosis with samples obtained from individuals 1-6 months and 7-30 months post SARS-CoV-2 infection. Semen parameters, thiobarbituric acid reactive substances, cyclooxygenase 2 expression by fluorescence immunocytochemistry and immunoblotting, prostaglandin levels by enzyme immunoassay, ornithine decarboxylase activity by a radioactive assay, and polyamine and acetylated polyamine levels by thin-layer chromatography were assessed. RESULTS In both groups of semen samples from coronavirus disease 2019 recovered men, sperm vitality, total and progressive sperm motility, and putrescine levels were significantly decreased when compared with samples from the uninfected group. In contrast, lipid peroxidation, leukocyte-associated cyclooxygenase 2 expression, and prostaglandin D2 levels were higher in semen from coronavirus disease 2019 recovered men than in samples from uninfected individuals. While sperm concentration and morphology, ornithine decarboxylase activity, and N-acetylputrescine levels were statistically diminished in semen obtained up to 6 months after coronavirus disease 2019 recovery, these parameters remained unchanged when samples were collected 7-30 months after coronavirus disease 2019 recovery. Coronavirus disease 2019 vaccination did not show negative effects on any of the parameters evaluated. DISCUSSION AND CONCLUSION Our work provides insights into the detrimental impact of coronavirus disease 2019 on several sperm parameters, in some cases, even more than a year after SARS-CoV-2 infection, which would be accompanied by alterations in the seminal fluid prostaglandin and polyamine profiles. Therefore, future treatments targeting the prostaglandin and polyamine pathways in coronavirus disease 2019 recovered men could lead to a successful reinstatement of semen parameters.
Collapse
Affiliation(s)
- María Eugenia Matzkin
- Laboratorio de Neuro-inmuno-endocrinología testicular, Instituto de Biología y Medicina Experimental (IBYME), Fundación IBYME, CONICET, Ciudad de Buenos Aires, Argentina
- Cátedra 1, Bioquímica Humana, Facultad de Medicina, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina
| | - Celina Beguerie
- Fertilis Medicina Reproductiva, San Isidro, Buenos Aires, Argentina
| | | | - Gustavo Martinez
- Fertilis Medicina Reproductiva, San Isidro, Buenos Aires, Argentina
| | - Mónica Beatriz Frungieri
- Laboratorio de Neuro-inmuno-endocrinología testicular, Instituto de Biología y Medicina Experimental (IBYME), Fundación IBYME, CONICET, Ciudad de Buenos Aires, Argentina
- Cátedra de Química, Ciclo Básico Común, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina
| |
Collapse
|
5
|
Li JZ, Wu H, Wang L, Wang YS, Kong F, Cao LQ, Liang M, Wang X, Yuan MZ. Male reproductive function before and after the adjustment of the COVID-19 prevention policy: a multicenter study in China. Asian J Androl 2024; 26:308-314. [PMID: 38639721 PMCID: PMC11156448 DOI: 10.4103/aja202388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 12/25/2023] [Indexed: 04/20/2024] Open
Abstract
At the end of 2022, the adjustment of the coronavirus disease 2019 (COVID-19) pandemic control policy in China resulted in a large-scale increase in public infection. To compare the fertility parameters of male patients before and after the adjustments of the COVID-19 pandemic control policy in China, we collected data on patients' medical histories and laboratory examinations on their first visits between June 2022 and March 2023 in five different hospitals. Data were divided into five groups according to the timeline of the policy adjustment. The data we collected from male patients included semen quality and serum reproductive hormone levels, and intergroup comparisons were made using the Mann-Whitney U and Chi-square tests. In total, 16 784 cases underwent regular semen analysis, 11 180 had sperm morphology assessments, and 7200 had reproductive hormone analyses. The data showed declining trends in semen volume, sperm motility, and the progressive sperm motility rate after the policy adjustment. Subgroup comparison revealed an initial decrease and gradual recovery in progressive motility rate. Sperm morphology analysis showed increased neck and tail abnormalities after the policy adjustment. No significant change in hormone levels was observed. Following the adjustment of the COVID-19 prevention policy in China, a decline in sperm motility and morphology was observed. This trend may gradually recover over 2 months. After the policy adjustment, reproductive hormone levels were relatively stable throughout, except for an increase in luteinizing hormone (LH). These changes in semen parameters suggest that the policy adjustment had a short- to medium-term impact on male reproductive function.
Collapse
Affiliation(s)
- Jian-Zheng Li
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250000, China
| | - Han Wu
- Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China
| | - Li Wang
- Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China
| | - Yun-Shan Wang
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250000, China
| | - Feng Kong
- Engineering Laboratory of Urinary Organ and Functional Reconstruction of Shandong Province, Jinan 250000, China
| | - Long-Qiao Cao
- The First People’s Hospital of Jining, Jining 272000, China
| | - Ming Liang
- Department of Reproductive Medicine, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250000, China
| | - Xiong Wang
- Reproductive Medicine Center, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China
| | - Ming-Zhen Yuan
- Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China
| |
Collapse
|
6
|
Zhang QF, Zhang YJ, Wang S, Wei Y, Zhang H, Li F, Deng YQ. Does COVID-19 affect sperm quality in males? the answer may be yes, but only temporarily. Virol J 2024; 21:24. [PMID: 38263068 PMCID: PMC10804479 DOI: 10.1186/s12985-024-02290-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Accepted: 01/06/2024] [Indexed: 01/25/2024] Open
Abstract
BACKGROUND The Corona Virus Disease 2019 (COVID-19) pandemic has raised concerns regarding its potential impact on male reproductive health. However, the impact of COVID-19 on sperm quality remains uncertain. This retrospective study aimed to investigate the short-term and relatively long-term effects of COVID-19 infection on sperm quality. METHODS A total of 85 males with fertility requirements, who underwent semen evaluation at Guilin People's Hospital between June 2022 and July 2023, were included in the study. Changes in semen parameters were analyzed across three specific timeframes: within 6 months before COVID-19 infection, within 3 months after COVID-19 infection, and 3-6 months after COVID-19 recovery. RESULTS The results revealed that the sperm concentration and total sperm number were significantly lower after infection compared to before, while in the recovery period, the sperm concentration, total sperm count, progressive motility, and normal morphology significantly increased. Comparing the three periods, the most significant difference was observed in sperm concentration, which exhibited a significant decrease after infection but returned to normal levels after recovery from COVID-19. CONCLUSIONS These findings suggest that COVID-19 may exert some impact on sperm quality, particularly evidenced by decreased sperm concentration post-infection. Fortunately, these effects on semen parameters appear to be temporary, with gradual restoration of semen parameters within 3-6 months after recovery. However, further research is needed to explore the underlying mechanisms and long-term implications of these observed changes in semen parameters.
Collapse
Affiliation(s)
- Qi-Feng Zhang
- Department of Andrology, Guilin People's Hospital, 541002, Guilin, China.
| | - Yu-Ji Zhang
- Department of Medical Record Management, The First Affiliated Hospital of Hainan Medical University, 571137, Haikou, China
| | - Sheng Wang
- Department of Urology, Guilin People's Hospital, 541002, Guilin, China
| | - Yu Wei
- Department of Urology, Guilin People's Hospital, 541002, Guilin, China
| | - Han Zhang
- Department of Urology, Guilin People's Hospital, 541002, Guilin, China
| | - Feng Li
- Department of Urology, Guilin People's Hospital, 541002, Guilin, China
| | - Yong-Quan Deng
- Department of Urology, Guilin People's Hospital, 541002, Guilin, China
| |
Collapse
|
7
|
Kumar Y, Kumari A, Kumar T, Jha K, Zabihullah M. Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients. Cureus 2023; 15:e45276. [PMID: 37846240 PMCID: PMC10576849 DOI: 10.7759/cureus.45276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/14/2023] [Indexed: 10/18/2023] Open
Abstract
Introduction Human coronaviruses, identified in the 1960s, are known culprits of respiratory infections. Classified into alpha, beta, gamma, and delta subgroups, these viruses have the capacity to transition from animal reservoirs to causing severe respiratory ailments in humans. Notable outbreaks like the 2003 severe acute respiratory distress syndrome (SARS) epidemic and the ongoing coronavirus disease 2019 (COVID-19) pandemic underscore the recurring emergence of novel coronaviruses with severe human infection potential. COVID-19, driven by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a leading global cause of severe acute respiratory syndrome. Immune system disruptions and cytokine imbalances contribute to severe cases, necessitating early diagnosis and precise severity assessment. Methodology This retrospective cross-sectional study encompassed 211 COVID-19 patients admitted to AIIMS Patna from May to July 2020. Clinical and hematological parameters, including neutrophils, eosinophils, basophils, lymphocytes, monocytes, red and white blood cell counts, platelet count, C-reactive protein (CRP), serum ferritin, and d-dimer, were meticulously recorded. Patients were categorized into non-severe and severe groups using the National Early Warning Score (NEWS) 2. Results Our findings underscore the pivotal role of hematological markers in gauging COVID-19 severity. Notably, markers such as neutrophil-to-lymphocyte ratio (NLR), derived NLR, lymphocyte monocyte ratio, platelet lymphocyte ratio, d-dimer, CRP, and serum ferritin exhibited notable elevation in severe cases. Survival analysis further established the predictive potential of these markers in assessing disease progression and mortality risk. We advocate for the integration of these markers into existing severity assessment frameworks to foster objective clinical evaluations. Conclusion In conclusion, our study unravels the intricate connection between COVID-19 severity and hematological parameters. We emphasize the early warning capabilities of NLR, derived NLR, platelet lymphocyte ratio, and other markers in predicting disease progression. This research underscores the imperative need to incorporate hematological markers into the evaluation of COVID-19 severity, thereby providing invaluable insights for enhancing clinical practice and patient outcomes.
Collapse
Affiliation(s)
- Yogesh Kumar
- Physiology, All India Institute of Medical Sciences, Patna, Patna, IND
| | - Amita Kumari
- Physiology, All India Institute of Medical Sciences, Deoghar, Deoghar, IND
| | - Tribhuwan Kumar
- Physiology, All India Institute of Medical Sciences, Patna, Patna, IND
| | - Kamlesh Jha
- Physiology, All India Institute of Medical Sciences, Patna, Patna, IND
| | - Md Zabihullah
- Physiology, All India Institute of Medical Sciences, Patna, Patna, IND
| |
Collapse
|
8
|
Zabihullah M, Kumar T, Jha K, Siddharth K, Ganguly A, Kumar Y, Mannan R. The Effect of Age on Semen Quality Among Male Partners of Infertile Couples: An Observational Study in a Tertiary Care Center in Eastern India. Cureus 2023; 15:e42882. [PMID: 37664284 PMCID: PMC10474524 DOI: 10.7759/cureus.42882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/02/2023] [Indexed: 09/05/2023] Open
Abstract
INTRODUCTION Male infertility contributes to a significant proportion of infertility cases, and advanced paternal age has been suggested to affect semen quality and fertility. However, the relationship between age and semen quality remains inconclusive, with conflicting findings reported in the literature. This study aimed to investigate the effect of age on semen quality among male partners of infertile couples in a tertiary care center in eastern India. METHODS A cross-sectional observational study was conducted, involving 390 male participants aged 21-50 years, who were referred to the andrology laboratory for semen analysis between January 2019 and December 2022. Participants were categorized into three age groups (21-30, 31-40, and 41-50 years). Semen parameters, including sperm concentration, semen volume, motility, and morphology, were assessed according to the World Health Organization guidelines. RESULTS Among the participants, no significant differences were observed in semen volume, motility, and morphology across different age groups. However, a statistically significant difference in sperm concentration among the three age groups was observed (p = 0.022). Spearman correlation analysis revealed a positive correlation between age and sperm concentration (r = 0.124, p = 0.013) as well as total sperm count (r = 0.10, p = 0.049). CONCLUSION In this study, no significant decline in semen quality with age was found among male partners of infertile couples aged 21-50 years. These findings highlight the complex relationship between age and semen quality and emphasize the need for further research to better understand the underlying mechanisms and provide more conclusive evidence regarding the impact of age on male fertility.
Collapse
Affiliation(s)
- Md Zabihullah
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| | - Tribhuwan Kumar
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| | - Kamlesh Jha
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| | - Kumar Siddharth
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| | - Abhimanyu Ganguly
- Physiology, Netaji Subhas Medical College and Hospital (NSMCH), Patna, IND
| | - Yogesh Kumar
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| | - Raihan Mannan
- Physiology, All India Institute of Medical Sciences (AIIMS), Patna, IND
| |
Collapse
|